Letermovir Noninferior for CMV Prophylaxis in Kidney Recipients

TUESDAY, June 13, 2023 -- Letermovir is noninferior to valganciclovir for prevention of cytomegalovirus (CMV) among CMV-seronegative kidney transplant recipients who receive an organ from a CMV-seropositive donor, according to a study published...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news